Stefanie Jilg
Munich, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Value of functional iron parameters in diagnostic re-assessment of MPN: refinement of iron-deficiency markers by zinc protoporphyrin (ZPP).
Journal: Annals of hematology
Published: April 16, 2026
Patient-reported outcomes regarding the use of complementary and alternative medicine (CAM) in BCR::ABL1-negative myeloproliferative neoplasias.
Journal: Journal of cancer research and clinical oncology
Published: June 23, 2025
MoReLife - real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients.
Journal: Annals of hematology
Published: May 20, 2024
Development of Highly Sensitive Digital Droplet PCR for Detection of cKIT Mutations in Circulating Free DNA That Mediate Resistance to TKI Treatment for Gastrointestinal Stromal Tumor (GIST).
Journal: International journal of molecular sciences
Published: January 24, 2023
Transcriptomic profiling does not refine mastocytosis diagnosis
Journal: Haematologica
Published: January 20, 2023
Elevated RIPK3 correlates with disease burden in myelofibrosis.
Journal: Blood advances
Published: December 31, 2021
Comprehensive characterization of central BCL-2 family members in aberrant eosinophils and their impact on therapeutic strategies.
Journal: Journal of cancer research and clinical oncology
Published: May 09, 2021
Cyclophosphamide plus etoposide is a safe and effective mobilization regimen in patients with multiple myeloma.
Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
Published: March 21, 2021
Inhibition of PLK1 by capped-dose volasertib exerts substantial efficacy in MDS and sAML while sparing healthy haematopoiesis.
Journal: European journal of haematology
Published: July 24, 2019
Last Updated: 09/26/2026